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Abstract The purpose of this study was to investigate the sub-
jective perception of anxiety pre- and post-procedure, and ex-
plore the relationship between demographic, clinical variables
and cancer patients’ anxiety during a positron emission
tomography/computed tomography (PET/CT) scan. Two hun-
dred and thirty-two oncological out patients, with clinical indi-
cation for performing an 18F-2-fluoro-2-deoxy-D-glucose (18F-
FDG) PET/CT scan and attending a nuclear medicine (NM)
department, participated in the study. Patients’ anxiety and sub-
jective experience of PET/CT were examined using two self-
report questionnaires. The pre-procedure questionnaire focused
on demographic information, level of knowledge regarding the
scan and subjective perception of anxiety before the procedure.
The post-procedure questionnaire included the subjective per-
ception anxiety after the procedure, information adequacy and
satisfaction with the NM department. The self-reported data
indicate that patients were anxious during PET/CT.
Furthermore, our data revealed a significant difference between
the anxiety pre-procedure and post-procedure (z = −3909,
p < 0.05), in which the anxiety pre-procedure has significantly
higher values. No significant correlation was found between
anxiety and age of the patients, education levels, adequacy of
information or satisfaction with the NM Department.
Perception of anxiety post-procedure differs between gender
(U = 5641, p = 0.033). In conclusion, PET/CT generated anx-
iety levels in oncological patients, especially before the proce-
dure. Although patients seemed to be satisfied with information
delivered by staff and with the NMDepartment, attention has to
be focused on effective interventions strategies that help pa-
tients to reduce anxiety.
Keywords Anxiety . Positron emission tomography . Patient
perspective . Oncology
Introduction
Anxiety is a complex reaction to potentially uncertain or dan-
gerous situations, anticipating and preparing the individual to
act and respond adequately [1, 2]. It is often associated with
physical symptoms such as muscle tension, fatigue, tremors
and frequent urination. Cancer patients commonly experience
emotional distress, including anxiety, as a response to the ini-
tial diagnosis and also throughout the course of the disease [3,
4], usually linked to fears related to the illness, such as pain,
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loss of social and professional roles, separation, uncertainty
towards the future and eventually, death [1, 2].
Medical imaging technologies and techniques have
evolved greatly in the last decade, with marked improvements
in the diagnosis and follow-up of diseases, especially in can-
cer. Positron emission tomography/computed tomography
(PET/CT) with 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG)
is a less invasive tool available for the assessment of patients
with suspected cancer [2, 5]. The use of 18F-FDG, an analogue
of glucose, contributes to the assessment of glucose metabo-
lism, which is increased in most cancers [5, 6], thus making
this a sensitive and useful imaging modality for diagnosis,
staging and restaging and assessing the response to therapy
of oncological patients [5]. PET/CT is a vital examination
among many tests that oncological patients are subjected to.
In this context, medical imaging can be perceived by can-
cer patients as a threat, causing fear and anxiety, as it may
confirm the diagnosis or change the therapeutic approach
[2]. Also, discomfort and claustrophobia are reported by pa-
tients, probably due to the confrontation with intimidating and
unfamiliar technology and more specifically, the confined na-
ture of the acquisition procedure [7, 8].
When performing a PET/CT with 18F-FDG, extensive and
diverse information is communicated to the patient. Prior to
the scan day, a brief and simple explanation of the procedure
should be given and also information regarding fasting times,
hydration and exercise. On the day of the scan, obtaining a
pertinent patient history and clear explanation is of utmost
importance to obtain image quality and diagnostic accuracy,
provide a comfortable and as minimal invasive experience as
possible for the patient [9]. However, high anxiety can affect
the patient’s experience and interfere with the workflow of the
nuclear medicine (NM) department (e.g. amount of extra time
spent to tranquillise the patient or the presence of movement-
related artefacts eventually requiring image repetition) [5, 8].
Additionally, the change in physiologic parameters caused by
anxiety may affect the normal biodistribution of 18F-FDG
(e.g. uptake of 18F-FDG in muscles or brown adipose tissue)
and interfere with the accurate results of the PET/CT [8, 9].
The purpose of this study was to investigate the subjective
perception of anxiety pre- and post-procedure, and explore the
relationship between demographic, clinical variables and can-
cer patients’ anxiety during a PET/CT scan.
Material and Methods
Participants
This cross-sectional prospective study was based on the
population of oncological patients with clinical indication
to perform PET/CT with 18F-FDG and who were 18 years
old or older.
A non-probabilistic sample included all consecutive onco-
logical patients who were scheduled for a PET/CT with 18F-
FDG in the NM department of a private clinic of Lisbon
(Portugal), between April 2014 and July 2014. All the patients
who participated in this study answered all the questions on
both questionnaires.
Exclusion criteria included patients aged under 18 years
old, visibly incapacitated, unable to understand the content
of the questionnaires and who had not totally filled in the
questionnaires. No restrictions were made as to cancer stage
or point in the process of treatment.
Prior to the study, authorisation from the department’s ad-
ministration board was obtained. The aim of the study was
orally explained to all patients and confidentiality and ano-
nymity were assured. All participants signed an informed con-
sent form. From the patients initially recruited, 14 (6 %) re-
fused to participate in the study and therefore the final sample
included 232 patients.
Procedure
Amember of the healthcare teammade initial contact with the
patient and introduced the study. Patients who agreed to par-
ticipate were asked to complete the questionnaires, after the
consent form was signed.
The patients filled in two self-report questionnaires at two
different moments of the PET/CT scan: on arrival at the NM
department and prior to any information from the Allied
health professionals (AHP) (pre-procedure) and immediately
after the end of the image acquisition (post-procedure), while
in the NM department. Patients received paper copies of the
two questionnaires. The PET/CT scan was performed on a
Siemens Biograph 16 PET/CT scanner; 90 min after an intra-
venous injection of 296–370 MBq (8–10 mCi) of 18F-FDG.
The scan was acquired from the base of the skull to the mid-
thigh. The acquisition time was 3 min/bed with total scanning
time being approximately 20 min.
Data Collection
Two questionnaires were developed involving a review of the
literature to identify the problems and needs of oncological
patients performing imaging scans. A pre-test was performed
in two steps: firstly, a draught of the questionnaires was
reviewed by the AHP team for a preliminary content valida-
tion and secondly, the questionnaires were administered to ten
patients undergoing PET/CT scan to point out potential prob-
lems and misunderstandings. Based on the feedback provided
by the pre-test, some questions were reworded and others
eliminated. The Portuguese version of the questionnaires
was used for the data collection.
The pre-procedure questionnaire comprised questions re-
lated to demographic information (e.g. age, gender and
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literacy) and the level of knowledge regarding the scan. The
subjective perception of pre-procedure anxiety was also
assessed through a ten-point Likert scale, previously used
for this purpose in other NM studies [10].
The post-procedure questionnaire explored the patient’s
experiences during the procedure and the performance of the
AHP. Close-ended questions assessed the AHP performance
regarding the communication of information, as well as the
patient need to seek further information prior to the scan. A
ten-point Likert scale was used for the assessment of the sub-
jective perception of anxiety, satisfaction with care and satis-
faction with the information provided.
Data Analysis
Normality was tested by using the Kolmogorov-Smirnov test.
The difference between the subjective perception of anxiety
pre-procedure and post-procedure was examined for statistical
significance using the Wilcoxon test.
The Spearman correlation coefficient test was applied to
study the relationship between age, adequacy of information
provided by the professional and satisfaction with the subjec-
tive perception of anxiety pre-procedure as well as post-
procedure.
Mann-Whitney test was used to compare subjective per-
ception of anxiety pre-procedure and post-procedure between
gender, prior PET/CT, whether there was any autonomous
research for information and information about the PET/CT
provided by AHP. In addition to these tests, the Kruskal-
Wallis test was used to compare the subjective perception of
anxiety pre- and post-procedure between the four educational
groups and the four options indicating the reasons for a PET/
CT, because the normality assumption was also not verified.
Data were analysed using SPSS version 22.0 for Windows.
The differences were considered statistically significant at a p
value less than 0.05.
Results
The sample consisted of 232 patients; male and female pa-
tients were almost equally represented. The mean age of the
patients included was of 61 ± 13.4 years (62.8 ± 13.1 years for
male and 59.4 ± 13.5 years for female) and are mostly edu-
cated with secondary education (59.9 %) (Table 1).
One hundred and sixty-five of the 232 patients (71.1 %)
underwent the scan for the first time. A total of 80.6 % knew
the reason to perform the PET/CT. The most frequently re-
ported reason to perform the PET/CTwas the Binitial staging^
of oncological disease (49.7 %). The majority of the patients
(69 %) reported not having searched for information prior to
the scan. Of the 72 patients that searched for information prior
to the scan, 54.5 % reported Bradiation effects^ as the main
predisposing concern factor. 73.7 % of the patients received
information related to the PET/CT procedure by the AHP. The
adequacy of information provided by the professionals pre-
sented a mean value of 7.3 ± 2.2. The overall mean satisfac-
tion with the department was 6.8 ± 2.4 (Table 1).
The mean level of anxiety perceived by the patient prior to
the procedure was 6.4 ± 2.7 and post-procedure was 5.7 ± 2.6.
There was a statistically significant difference between the
anxiety pre-procedure and post-procedure (z = −3909,
p = 0.000) in which the anxiety post-procedure has signifi-
cantly lower values.
From the analysis of the variables that could affect the
subjective perception of anxiety pre-procedure and post-pro-
cedure, no significant correlation was found with the age of
the patients, adequacy of information provided or global sat-
isfaction as shown in Table 2.
The relationship between patients that underwent the scan
for the first time and subjective perception of anxiety pre- and
post-procedure was not significant (U = 4657.5, p = 0.058;
U = 4743.5, p = 0.088, respectively).
In relation to gender, there was no significant difference
between men and women in the subjective perception of anx-
iety before the procedure (U = 5803.5, p = 0.07). However, the
subjective perception of anxiety post-procedure differs signif-
icantly between men and women (U = 5641, p = 0.033), with
men presenting higher values.
No statistically significant differences were found in sub-
jective perception of anxiety pre-procedure and reason to per-
form the PET/CT scan (K-W = 0.857, p = 0.836) and educa-
tion levels (K-W = 0.984, p = 0.805). No such significant
difference exists in subjective perception of anxiety post-
procedure and reason to perform the PET/CT scan (K-
W = 2.303, p = 0.512) and education levels (K-W = 1.299,
p = 0.729).
The relationship between patients that searched for infor-
mation prior to the scan and subjective perception of anxiety
pre-procedure was not significant (U = 5679.5, p = 0.864),
neither was significantly different the subjective perception of
anxiety post-procedure (U = 4918.5, p = 0.073).
Discussion
The present study provided detailed understanding of the anx-
iety levels during a PET/CT scan. Our results indicate that
cancer patients experience anxiety during the PET/CT scan.
Anxiety levels were higher prior to the scan (6.4 ± 2.7), prob-
ably reflecting initial anxiety related to the scan procedure and
environment. Post scan anxiety levels were significantly lower
(5.7 ± 2.6), suggesting that a considerable part of the anxiety
felt by the patient is related with the imaging procedure itself.
Lledó et al. [10], in a research with patients that underwent
conventional NM scans, obtained a perception of anxiety
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result of 4.3 while the procedure was being carried out. The
average levels of anxiety in our study are clearly higher than
those found by Lledó et al. [10], whether before or after the
scan. This difference may be related with the inclusion criteria
of both studies: in our study only oncological patients were
included whereas in Lledó et al. [10] patients were randomly
included from all the NM procedures, suggesting that
oncological patients are exposed to higher levels of anxiety.
In fact, our results are in accordance with the literature [11],
showing that the majority of the patients performed the PET/
CT scan for initial staging of an oncological disease and, for
the remaining patients, the reasons for performing the PECT/
CT scan were directly related with the progression of the dis-
ease. In both cases, the outcome of the scan will provide
Table 1 Characteristics of study
patients and mean (SD) on
information provided, global
satisfaction and subjective
perception of anxiety perceived
by patients
Variable Mean ± SD Number (N) Percentage (%)
Gender
Male
Female
113 48.7
119 51.3
Age 61 ± 13.4 232
Education
Without studies
Basic education (6–15 years)
Secondary education (15–17 years)
Higher education (17 years+)
12 5.2
50 21.6
139 59.9
31 13.4
First PET/CT
Yes
No
165 71.1
67 28.9
Reason for PET/CT
Initial staging
Characterisation
Assess response to treatment
Exclude recurrence
Does not know
93 49.7
27 14.4
35 18.7
32 17.1
45 19.4
Autonomous information seeking
Yes
No
72 31.0
160 69.0
Information provided by AHP
Yes
No
171
61
73.7
26.3
Adequacy of information provided
by the professionals
7.3 ± 2.2 232
Global satisfaction with NM Department 6.8 ± 2.4 232
Anxiety pre-procedure 6.4 ± 2.7 232
Anxiety post-procedure 5.7 ± 2.6232
Table 2 Correlation between
age, adequacy of information
provided and global satisfaction
on subjective perception of
anxiety
Anxiety
Pre-procedure
ρ (p value)
Post-procedure
ρ (p value)
Age (global)
Age (male)
Age (female)
0.033 (0.618)
0.058 (0.545)
−0.016 (0.863)
−0.040 (0.542)
−0.042 (0.659)
−0.078 (0.3999)
Adequacy of information provided
by the professionals
−0.025 (0.742) −0.032 (0.675)
Global satisfaction −0.058 (0.381) −0.037 (0.578)
Significance was determined using Spearman’s correlation coefficient (p value statistically significant at <0.05)
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information regarding the disease and so, anxiety appears as a
response to the uncertainty towards this result [1, 2].
Additionally, the anxiety results are above the midpoint on
the Likert scale and, therefore, should not be disregarded as
it is known that high anxiety levels affect 18F-FDG
biodistribution (e.g. uptake of 18F-FDG in muscles or brown
adipose tissue), interfering with the accurate results of the
PET/CT. Also, considering that muscular tension associated
with anxiety can cause pain and discomfort in a scan like PET/
CT [12], it is important to emphasise anxiety as a relevant
factor for patient safety.
Despite being the first PET/CT for 71.1 % of the sub-
jects, we found no statistically significant differences in
the subjective perception of anxiety between these pa-
tients and those who had already undergone PET/CT pre-
viously. Previous research has demonstrated that even pa-
tients who had undergone PET/CT previously also expe-
rience high levels of anxiety, which was thought to be
related with an anticipatory effect regarding its possible
negative result [2]. Further, the anxiety levels of patients
who underwent PET/CT for the first time could be related
to the lack of knowledge about the procedure, possible
side effects and its result [2]. With reference to the reason
behind performing the scan, it was established that the
majority of the patients’ scans were carried out in the
context of initial staging of an oncology disease.
Considering that almost two thirds of the patients in our
study performed the scan for their first time, a possible
justification for the high pre-procedure anxiety levels is
the fear of the unknown regarding the procedure and the
effects of radiation. Although the levels of anxiety de-
crease post-procedure, these should not be ignored.
Although almost 20 % of patients included in our study
reported not receiving any information before the procedure,
the information provided by the professionals was felt to be
adequate (7.3 ± 2.2). This seems to be an unusual result since
the patient’s lack of understanding of a PET/CTwith 18F-FDG
and conventional NM is a recurring theme in literature.
According to Nightingale et al. [13], during the administration
of a cardiac SPECT/CT, some patients at the NM department
appeared to have an incomplete understanding of the proce-
dures, some of which seemed surprised during the explanation
of such procedures. The lack of understanding in relation to
the scan was also previously identified by Groves et al. [14],
who noticed patients were astounded by the complexity of the
scan and were consequently poorly prepared for it. On the
other hand, our results disagree with what Domènech et al.
[1] found, who reported that the quality of information influ-
ences the perception of anxiety.
From our results, 69 % of the patients admitted not hav-
ing looked up information relevant to the scan before un-
dergoing the procedure. In agreement with De Man et al.
[15], it is possible that these patients avoided researching
information as a coping strategy. In addition, the result
attained foresees that the majority of patients count on
the AHP as the main source of information, which high-
lights the essential role they have in preparing for the scan.
In this way, the AHP during the initial contact with the
patient should assess whether there has been prior research
for information and whether the patient needs any clarifi-
cation. It is common knowledge that a negative effect can
be caused by anxiety on clinical outcomes and the general
patient experience. The execution of a diagnostic scan such
as a PET/CT, where the information transmitted is exten-
sive, requires effective communication that allows the pa-
tient to understand and memorise the information as well
as anticipating emotional reactions. In a scan with the PET/
CT characteristics, the absence of information may be con-
sidered serious as it could jeopardise the patient’s safety
and the quality of the scan.
Very few studies evaluating prior awareness of PET/CTscan
were found when reviewing the literature [16, 17]. Similarly to
our study, the results obtained by Andersson et al. [16] show
that, despite 26 % of the patients not having a prior knowledge
of PET/CT, the image quality was not affected.
In accordance with what Pifarré et al. [2] found in their
PET-CT study, in our research, it was found that men evince
greater anxiety than women (U = 5641, p = 0.033). More
investigation is needed to further explore the difference in
anxiety between gender, as this is not a common result in other
studies [13, 18].
The insight to the treatment being received at the NM de-
partment is fundamental for patient satisfaction. The degree of
global satisfaction with the NM department was 6.8 ± 2.4. In
fact, 61.4 % of patients felt that they had the chance to explain
their concerns to an AHP, who is also reported by Andersson
et al. [16] who found that 65–70 % of the patients were satis-
fied with the interaction with the nursing staff, their commu-
nication abilities and professional skills. Although the satis-
faction in our study was high, Reyes-Perez [19] obtained a
higher satisfaction level (8.96). According to Lledó et al.
[10], patients that have the chance to explain themselves feel
more satisfied.
Considering the levels of anxiety both pre- and post-
procedure found in our study, it suggests that AHP should
focus on implementing specific strategies to reduce anxiety
related to PET/CT, and possibly interfere with patients’ well-
being and diagnostic accuracy.
Anxiety reduction strategies, like the following, have
been proved to be valuable in this regard. For information
improvement, Andersson et al. [20] suggest a website
with information about PET/CT procedures to increase
patient knowledge before the scan. Information should
be understandable and not include details about radiation,
risks factors and potential adverse reactions of intrave-
nous radiopharmaceutical since these matters increase
J Canc Educ
the patient’s anxiety level [20]. Furthermore, information
needs to be complemented with positive interaction (trust
and reassurance) between AHP and patient. Acuff et al.
[21] found that making patients aware that they can con-
tact the AHP during imaging helps to lower their anxiety.
Apart from using audiovisual imagery in the PET/CT up-
take room [8], which has proved to lower patient anxiety,
the use of music as environmental distraction may also be
used as a coping strategy for the patient [21]. Habituation
in a PET/CT simulator before the scan [22], a visit to the
control room before imaging, a device to signal for ad-
justment of music volume and a clock visible during scan
procedure [20, 23] are also relatively simple changes that
have been introduced with success in MR imaging and
could be used in PET/CT. Further research including
these strategies would make possible to investigate the
association between oncological patients referred for stag-
ing and anxiety.
Limitations
The current study has some limitations. Two questionnaires
were used to collect data in the present study. Some of the
questions were constructed by the authors for this particular
study and had not been tested before with regard to validity
and reliability, which limits the possibility of internal validity
of the present study. However, the response rate was high and
the low number of unanswered questionnaires indicates that
the patients found the questionnaires relevant and easy to un-
derstand. Being one of the first investigations on patients’
experiences of PET/CT scan and an exploratory study, it con-
tributes with relevant findings to this unexplored area of
research.
Conclusion
When performing PET/CT scans, oncological patients per-
ceive a high level of anxiety, independently of the clinical
reason for having the examination. The information related
with the procedure provided by healthcare professionals was
found to be an important factor in decreasing the overall per-
ception of anxiety, and therefore it should be used as a strategy
for coping, especially in the pre-procedure phase, where the
anxiety levels are higher. Additionally, male patients were
found to have higher levels of anxiety and strategies should
be implemented specifically for this group of patients. The
goal is to obtain PET/CT quality images while making the
patient experience as non-invasive as possible. In fact, by
decreasing the patient’s anxiety, the AHP can improve pa-
tients’ comfort and their overall experience.
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